ArticleThe Malaysian journal of medical sciences : MJMS2025
Neurodevelopment and Gross Motor Function Outcomes in Children at Risk or Diagnosed with Cerebral Palsy using Snoezelen Multisensory Room.
Article in The Malaysian journal of medical sciences : MJMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Snoezelen multisensory room is an internationally recognised intervention designed to provide sensory stimulation that promotes developmental progress in children. This study aimed to evaluate neurodevelopmental and gross motor outcomes in children at risk of, or diagnosed with, cerebral palsy and who received neurodevelopmental therapy in the Snoezelen multisensory room at Hospital Pakar Universiti Sains Malaysia, Kelantan. Methods: Twenty-six patients aged three to 24 months, either at risk of or diagnosed with cerebral palsy, were recruited. However, only 20 patients completed the study. All participants underwent neurodevelopmental therapy in the Snoezelen multisensory room for 12 weeks. Demographic and clinical characteristics were recorded. Neurodevelopment was assessed using the Hammersmith Infant Neurological Examination (HINE), and gross motor function was evaluated using the Gross Motor Function Measure (GMFM-88) scores. Assessments were performed before therapy and after 12 weeks. Pre- and post-therapy scores were compared using paired Results: HINE scores increased significantly from pre-therapy (mean = 60.70, standard deviation [SD] = 16.19) to post-therapy (mean = 66.75, SD = 18.18; Conclusion: Neurodevelopmental therapy delivered in a Snoezelen multisensory room was associated with significant improvements in neurodevelopmental and gross motor function after 12 weeks among children at risk of cerebral palsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.